🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Osimertinib combined with savolitinib in the treatment of EGFR mutated osim...
Status
Recruiting
Location
Qingdao Central Hospital
Start Date
2025-01-01
Trial ID
NCT07322783
Treatments Being Tested
Clinical study to investigate the efficacy and safety of savolitinib in com...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-08-03
Trial ID
NCT05261399
Treatments Being Tested
Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-06-25
Trial ID
NCT03944772
This study will compare the activity of the combination of savolitinib and ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-09-28
Trial ID
NCT04606771
Treatments Being Tested
This study (the SAVANNAH study) will investigate the efficacy of osimertini...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-09
Trial ID
NCT03778229
Treatments Being Tested
The purpose of this study is to assess the Treatment Strategies and Surviva...
Status
Recruiting
Location
Yongchang Zhang
Start Date
2020-04-16
Trial ID
NCT04322890
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and prel...
Status
Active Not Recruiting
Location
Research Site
Start Date
2014-08-05
Trial ID
NCT02143466
Treatments Being Tested
This study will look at how effective the study drug(Savolitinib combined w...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2021-11-22
Trial ID
NCT05015608
Treatments Being Tested
This is a prospective, pilot, two-arm, randomized, multicenter study explor...
Status
Active Not Recruiting
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Start Date
2022-05-31
Trial ID
NCT05163249
Treatments Being Tested
A Phase III Clinical Study on Savolitinib Combined with Osimertinib in Trea...
Status
Active Not Recruiting
Location
Guangdong General Hospital
Start Date
2021-09-06
Trial ID
NCT05009836
Treatments Being Tested